Eidos Therapeutics, Inc.

8-K

Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, New Financial Obligation or Off-Balance Sheet Arrangement, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

01/26/21

8-K

Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc

01/20/21

8-K

Other Events

01/12/21

8-K

Reports Third Quarter 2020 Financial Results and Business Update

10/29/20

8-K

Material Definitive Agreement, Financial Statements or Exhibits

10/07/20

8-K

######### ###### ### ##### ############ ######## ###### #########

10/05/20

8-K

######## ############

09/29/20

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Eidos Therapeutics, Inc. Watch